| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |